Readystate Asset Management LP bought a new stake in Avantor, Inc. (NYSE:AVTR – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 588,878 shares of the company’s stock, valued at approximately $13,444,000. Readystate Asset Management LP owned approximately 0.09% of Avantor as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Park Place Capital Corp lifted its position in Avantor by 18.2% in the third quarter. Park Place Capital Corp now owns 3,039 shares of the company’s stock worth $64,000 after buying an additional 467 shares during the last quarter. Cibc World Market Inc. raised its holdings in shares of Avantor by 1.3% in the first quarter. Cibc World Market Inc. now owns 36,082 shares of the company’s stock valued at $1,220,000 after acquiring an additional 480 shares in the last quarter. Dynamic Advisor Solutions LLC raised its holdings in shares of Avantor by 3.2% in the third quarter. Dynamic Advisor Solutions LLC now owns 18,598 shares of the company’s stock valued at $392,000 after acquiring an additional 579 shares in the last quarter. Vontobel Holding Ltd. raised its holdings in shares of Avantor by 2.0% in the fourth quarter. Vontobel Holding Ltd. now owns 30,215 shares of the company’s stock valued at $690,000 after acquiring an additional 591 shares in the last quarter. Finally, Cetera Advisor Networks LLC raised its holdings in shares of Avantor by 4.1% in the fourth quarter. Cetera Advisor Networks LLC now owns 15,881 shares of the company’s stock valued at $363,000 after acquiring an additional 622 shares in the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Avantor
In other Avantor news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the completion of the transaction, the executive vice president now directly owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Avantor
Avantor Stock Performance
NYSE AVTR traded down $0.22 during trading hours on Wednesday, reaching $24.38. The stock had a trading volume of 5,696,340 shares, compared to its average volume of 5,732,252. The stock has a fifty day moving average of $24.89 and a 200 day moving average of $22.42. The stock has a market cap of $16.54 billion, a P/E ratio of 50.79, a price-to-earnings-growth ratio of 1.56 and a beta of 1.37. Avantor, Inc. has a 52-week low of $16.63 and a 52-week high of $26.16. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.05 and a current ratio of 1.61.
Avantor (NYSE:AVTR – Get Free Report) last issued its earnings results on Wednesday, February 14th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.03. The firm had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a return on equity of 14.11% and a net margin of 4.61%. Avantor’s revenue for the quarter was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 earnings per share. Sell-side analysts predict that Avantor, Inc. will post 1.01 earnings per share for the current year.
Avantor Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Articles
- Five stocks we like better than Avantor
- How to Use High Beta Stocks to Maximize Your Investing Profits
- United Airlines Soars on Earnings Beat
- ETF Screener: Uses and Step-by-Step Guide
- J.B. Hunt Hits the Skids: Lower Prices to Come
- 3 Healthcare Dividend Stocks to Buy
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.